CLOV vs GILD
Clover Health Investments Corp (CLOV) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CLOV currently screens at market cap $1.55B. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CLOV and GILD stock pages for the full models.
Not investment advice.